Sign up online today & collaborate
or click here to find out more
Abingdon, UK - AMSBIO has published a new 36-page catalogue that details its comprehensive range of high purity reagents for proteoglycan and glycosaminoglycan research.
Proteoglycans are glycosylated proteins which contain covalently attached highly anionic glycosaminoglycans (GAGs). Proteoglycans are present in different forms within different types of extracellular matrices and connective tissues. Heparan sulfate proteoglycans (HSPGs) are known to play important structural and functional roles in linking the component proteins of the basement membrane, controlling the permeability properties of the membranes and signal transduction. Chondroitin Sulfate Proteoglycans (CSPGs) are involved in the inhibition of axon regeneration after various forms of damage to the Central Nervous System.
The new catalogue provides detailed information on AMSBIO’s extensive range of products for glycobiology research including antibodies, enzymes, assay kits, substrates and standards. AMSBIO is the leading supplier of antibodies that recognize defined epitopes within the carbohydrate (GAG) domains of proteoglycans; and also GAG-degrading chondrotinase, heparinase, hyaluronidase and keratanase enzymes, again with specific and defined activities. These can be used together to detect subtle differences or changes within the structure of GAGs.
In addition to product information the catalogue brings together useful background materials associated with this research area including an introduction to the structure / composition of proteoglycans and glycosaminoglycans as well as the latest research papers citing use of AMSBIO high purity reagents and assay kits.
For a copy of the new catalogue or further information on the cutting edge neuroscience range please visit www.amsbio.com/Proteoglycans-Glycosaminoglycans.aspx or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / email firstname.lastname@example.org.
Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as an expert in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance organoid and spheroid type screening outcomes from a technological and cost-effective perspective.
Dr Bill Bradbury email@example.com